Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-19-019932
Filing Date
2019-11-06
Accepted
2019-11-06 17:01:37
Documents
77
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 848669
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 11073
3 EXHIBIT 32.1 ex32_1.htm EX-32.1 6576
  Complete submission text file 0001140361-19-019932.txt   5713584

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rexn-20190930.xml EX-101.INS 1467225
5 XBRL TAXONOMY EXTENSION SCHEMA rexn-20190930.xsd EX-101.SCH 51395
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rexn-20190930_cal.xml EX-101.CAL 49305
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rexn-20190930_def.xml EX-101.DEF 161785
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rexn-20190930_lab.xml EX-101.LAB 378800
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rexn-20190930_pre.xml EX-101.PRE 330466
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34079 | Film No.: 191197104
SIC: 2834 Pharmaceutical Preparations